Drug Profile
Influenza vaccine quadrivalent - PT Bio Farma
Alternative Names: QIV - PT Bio FarmaLatest Information Update: 17 Mar 2021
Price :
$50
*
At a glance
- Originator PT Bio Farma
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 17 Mar 2021 No development reported - Phase-II for Influenza virus infections (In adolescents, In children, In infants, Prevention, In adults) in Indonesia (Parenteral)
- 30 Nov 2018 PT Bio Farma completes a phase II trial in Influenza virus infections (In adolescents, In adults, In children, In infants, Prevention) in Indonesia (NCT03336593)
- 21 Nov 2017 Phase-II clinical trials in Influenza virus infections (Prevention, In infants, In children, In adults, In adolescents) in Indonesia (Parenteral) (NCT03336593)